Education and Knowledge in Pharmacogenomics: Still a Challenge?

Jyothsna Giri; Timothy B Curry; Christine M Formea; Wayne T Nicholson; Carolyn R Rohrer Vitek

doi:10.1002/cpt.1019

Education and Knowledge in Pharmacogenomics: Still a Challenge?

Clin Pharmacol Ther. 2018 May;103(5):752-755. doi: 10.1002/cpt.1019. Epub 2018 Feb 8.

Authors

Jyothsna Giri¹, Timothy B Curry², Christine M Formea³, Wayne T Nicholson², Carolyn R Rohrer Vitek¹

Affiliations

¹ Mayo Clinic College of Medicine, Center for Individualized Medicine, Rochester, Minnesota, USA.
² Mayo Clinic College of Medicine, Department of Anesthesiology and Perioperative Medicine, Rochester, Minnesota, USA.
³ Mayo Clinic College of Medicine, Department of Pharmacy, Rochester, Minnesota, USA.

PMID: 29417560
DOI: 10.1002/cpt.1019

Abstract

A number of barriers exist for adoption of pharmacogenomics into practice. Physicians, pharmacists, and nurses report limited knowledge about pharmacogenomics and its use in patient care. Lack of pharmacogenomics education curricula as part of professional schools or postgraduate training programs has been reported as a potential cause. Understanding pharmacogenomics is further complicated by a complex and nonstandard lexicon, limited medication guidelines, rapidly changing evidence, and insufficient awareness of test availability and utility.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Curriculum
Education, Pharmacy / methods
Health Knowledge, Attitudes, Practice
Humans
Patient Care / methods
Pharmacists
Pharmacogenetics / education*
Physicians
Professional Role